Premium Grade | UK Supply | Research Peptide | COA Certified | >99% Purity | Worldwide Delivery

(Octacontapeptide, 83 amino acids)
(Tetrasectide, 44 amino acids)

Why IGF-1 LR3 and CJC-1295+DAC Make a Strong Research Pairing

IGF-1 LR3 and CJC-1295+DAC form a scientifically relevant pairing because they allow researchers to investigate two different levels of growth-related signalling. CJC-1295+DAC is primarily studied through growth hormone-releasing hormone receptor activity, while IGF-1 LR3 is examined through direct interaction with the insulin-like growth factor-1 receptor.

The Drug Affinity Complex attached to CJC-1295 is designed to support albumin binding and extend the compound’s measurable signalling profile. Laboratory research commonly examines GHRH receptor activation, cyclic AMP and protein kinase A signalling, peptide stability, albumin association and time-dependent changes within the wider GH–IGF-1 signalling axis.

IGF-1 LR3 is a modified IGF-1 analogue with an extended amino-acid sequence and altered binding characteristics. Its research profile focuses on IGF-1 receptor activation and downstream pathways such as PI3K/Akt and MAPK/ERK. These pathways are studied in connection with cellular growth signalling, protein-synthesis markers, metabolic regulation and cell-differentiation models.

Studying these compounds within the same research programme enables researchers to compare an upstream GHRH-receptor pathway compound with a downstream IGF-1-receptor pathway compound. This distinction is valuable because the two materials should not be treated as interchangeable, even though both connect with the broader GH–IGF-1 research axis.

Experimental models may examine receptor activation, phosphorylation patterns, gene-expression changes, pathway duration and cellular response markers. Each compound can first be assessed independently before findings are compared across matched conditions. Together, IGF-1 LR3 and CJC-1295+DAC provide a complementary framework for investigating receptor identity, signalling duration and communication between upstream endocrine pathways and downstream growth-factor signalling.

Explore Each Research Compound
Continue examining each research compound separately and compare their respective receptor activity and growth-related signalling pathways.

View IGF-1 LR3 1mg Research Compound ⟶
View CJC-1295+DAC 5mg Research Compound ⟶

Explore Related Research Compounds
Continue exploring related laboratory research products from BioPlex Peptides.

View CJC-1295 10mg and Ipamorelin 10mg Research Set ⟶
View CJC-1295 10mg and GHRP-6 10mg Research Set ⟶

Research Preparation and Guidance
Access relevant BioPlex collections, preparation tools and guidance for structured laboratory research.

Explore the Myogenic Research Peptides Collection ⟶
View Reconstitution Solutions ⟶
Use the Peptide Reconstitution Calculator ⟶

Explore Related Research Articles
Continue your research with detailed BioPlex articles covering compound structures, scientific mechanisms and laboratory research pathways.

Peptides for Muscle Growth Research: IGF-1 LR3 and CJC-1295 ⟶
Science Research Studies: CJC-1295 vs CJC-1295+DAC ⟶
Science Research Studies: GHRH Explained ⟶

Disclaimer

For research purposes only, Not for human consumption